We reach more than 65,000 registered users in Dec!! Register Now
Novartis and Sangamo partner on zinc finger therapies for autism and intellectual disability
- August 02, 2020
- 64 Views
- 0 Likes
- 0 Comment
The firms are developing a modified version of the gene-editing technology to boost the expression of genes
Cite This Article as
"Novartis and Sangamo partner on zinc finger therapies for autism and intellectual disability", MachPrinciple, August 02, 2020, https://machprinciple.com/post/Novartis-and-Sangamo-partner-on-zinc-finger-therapies-for-autism-and-intellectual-disability
No tags found for this post
